Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients

Abstract Background The identification of novel functional biomarkers is essential for recognizing high-risk patients, predicting recurrence, and searching for appropriate treatment. However, no prognostic biomarker has been applied for colorectal cancer (CRC) in the clinic. Methods Integrated with...

Full description

Bibliographic Details
Main Authors: Wei Zhang, Liewen Lin, Ligang Xia, Wanxia Cai, Weier Dai, Chang Zou, Lianghong Yin, Donge Tang, Yong Xu, Yong Dai
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-021-02939-7
_version_ 1818914448662855680
author Wei Zhang
Liewen Lin
Ligang Xia
Wanxia Cai
Weier Dai
Chang Zou
Lianghong Yin
Donge Tang
Yong Xu
Yong Dai
author_facet Wei Zhang
Liewen Lin
Ligang Xia
Wanxia Cai
Weier Dai
Chang Zou
Lianghong Yin
Donge Tang
Yong Xu
Yong Dai
author_sort Wei Zhang
collection DOAJ
description Abstract Background The identification of novel functional biomarkers is essential for recognizing high-risk patients, predicting recurrence, and searching for appropriate treatment. However, no prognostic biomarker has been applied for colorectal cancer (CRC) in the clinic. Methods Integrated with transcriptomic data from public databases, multi-omics examinations were conducted to search prognostic biomarkers for CRC. Moreover, the potential biological functions and regulatory mechanism of these predictive genes were also explored. Results In this study, we revealed that three mitochondrial genes were associated with the poor prognosis of CRC. Integrated analyses of transcriptome and proteome of CRC patients disclosed numerous down-regulated mitochondrial genes at both mRNA and protein levels, suggesting a vital role of mitochondria in carcinogenesis. Combined with the bioinformatics studies of transcriptomic datasets of 538 CRC patients, three mitochondrial prognostic genes were eventually selected out, including HIGD1A, SUCLG2, and SLC25A24. The expression of HIGD1A exhibited a significant reduction in two subtypes of adenoma and six subtypes of CRC, while the down-regulation of SUCLG2 and SLC25A24 showed more advantages in rectal mucinous adenocarcinoma. Moreover, we unveiled that these three genes had common expressions and might collaboratively participate in the synthesis of ribosomes. Our original multi-omics datasets, including DNA methylation, structural variants, chromatin accessibility, and phosphoproteome, further depicted the altered modifications on their potential transcriptional factors. Conclusions In summary, HIGD1A, SUCLG2, and SLC25A24 might serve as predictive biomarkers for CRC. The biological activities they involved in and their upstream regulators we uncovered would provide a functional context for the further-in-depth mechanism study. Graphic abstract
first_indexed 2024-12-19T23:46:30Z
format Article
id doaj.art-4bc677e5e2d34c3182029ea343aaac2f
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-12-19T23:46:30Z
publishDate 2021-06-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-4bc677e5e2d34c3182029ea343aaac2f2022-12-21T20:01:18ZengBMCJournal of Translational Medicine1479-58762021-06-0119111610.1186/s12967-021-02939-7Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patientsWei Zhang0Liewen Lin1Ligang Xia2Wanxia Cai3Weier Dai4Chang Zou5Lianghong Yin6Donge Tang7Yong Xu8Yong Dai9Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital)Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital)Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital)Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital)College of Natural Science, University of Texas at AustinDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital)Department of Nephrology, Institute of Nephrology and Blood Purification, The First Affiliated Hospital of Jinan University, Jinan UniversityDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital)The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s HospitalDepartment of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, The Second Clinical Medical College, Jinan University (Shenzhen People’s Hospital)Abstract Background The identification of novel functional biomarkers is essential for recognizing high-risk patients, predicting recurrence, and searching for appropriate treatment. However, no prognostic biomarker has been applied for colorectal cancer (CRC) in the clinic. Methods Integrated with transcriptomic data from public databases, multi-omics examinations were conducted to search prognostic biomarkers for CRC. Moreover, the potential biological functions and regulatory mechanism of these predictive genes were also explored. Results In this study, we revealed that three mitochondrial genes were associated with the poor prognosis of CRC. Integrated analyses of transcriptome and proteome of CRC patients disclosed numerous down-regulated mitochondrial genes at both mRNA and protein levels, suggesting a vital role of mitochondria in carcinogenesis. Combined with the bioinformatics studies of transcriptomic datasets of 538 CRC patients, three mitochondrial prognostic genes were eventually selected out, including HIGD1A, SUCLG2, and SLC25A24. The expression of HIGD1A exhibited a significant reduction in two subtypes of adenoma and six subtypes of CRC, while the down-regulation of SUCLG2 and SLC25A24 showed more advantages in rectal mucinous adenocarcinoma. Moreover, we unveiled that these three genes had common expressions and might collaboratively participate in the synthesis of ribosomes. Our original multi-omics datasets, including DNA methylation, structural variants, chromatin accessibility, and phosphoproteome, further depicted the altered modifications on their potential transcriptional factors. Conclusions In summary, HIGD1A, SUCLG2, and SLC25A24 might serve as predictive biomarkers for CRC. The biological activities they involved in and their upstream regulators we uncovered would provide a functional context for the further-in-depth mechanism study. Graphic abstracthttps://doi.org/10.1186/s12967-021-02939-7Prognostic biomarkersMitochondriaMulti-omics studyColorectal cancerRibosome
spellingShingle Wei Zhang
Liewen Lin
Ligang Xia
Wanxia Cai
Weier Dai
Chang Zou
Lianghong Yin
Donge Tang
Yong Xu
Yong Dai
Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
Journal of Translational Medicine
Prognostic biomarkers
Mitochondria
Multi-omics study
Colorectal cancer
Ribosome
title Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
title_full Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
title_fullStr Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
title_full_unstemmed Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
title_short Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
title_sort multi omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients
topic Prognostic biomarkers
Mitochondria
Multi-omics study
Colorectal cancer
Ribosome
url https://doi.org/10.1186/s12967-021-02939-7
work_keys_str_mv AT weizhang multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT liewenlin multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT ligangxia multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT wanxiacai multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT weierdai multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT changzou multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT lianghongyin multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT dongetang multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT yongxu multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients
AT yongdai multiomicsanalysesofhumancolorectalcancerrevealedthreemitochondrialgenespotentiallyassociatedwithpooroutcomesofpatients